Welcome to our dedicated page for Owens & Minor news (Ticker: OMI), a resource for investors and traders seeking the latest updates and insights on Owens & Minor stock.
Owens & Minor, Inc. (NYSE: OMI) is a prominent healthcare logistics company specializing in the distribution and logistics of medical products. The company plays a crucial role in ensuring the seamless delivery of vital medical supplies from manufacturers to healthcare providers. With a presence in both the United States and Europe, Owens & Minor operates strategically positioned logistics platforms that serve markets responsible for three-quarters of global healthcare spending.
Headquartered in Richmond, Virginia, this Fortune 500 company boasts annualized revenues exceeding $9 billion. Owens & Minor's diverse customer base includes independent hospitals, large integrated healthcare networks, group purchasing organizations, healthcare product manufacturers, and the federal government.
Owens & Minor operates under two main segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment focuses on the manufacturing and sourcing of medical-surgical products. This segment also provides solutions to prevent healthcare-associated infections across various healthcare settings. On the other hand, the Patient Direct segment delivers disposable medical supplies directly to patients and home health agencies, enhancing the accessibility of essential healthcare products.
Recent achievements include strategic partnerships to expand their reach and optimize their supply chain operations. These initiatives aim to enhance service efficiency, ensuring that patients receive necessary medical supplies promptly and healthcare providers can focus on delivering quality care.
Owens & Minor's unwavering commitment to innovation and quality has positioned it as a leader in healthcare logistics. For more detailed information, visit their official website.
Owens & Minor has launched a pilot program in Southern California using an electric semi-truck to deliver medical products and PPE. The program, developed in partnership with Penske Logistics, began in the second quarter and will run for seven months. The Freightliner eCascadia will operate five days a week along a 152-mile route, stopping at five hospitals. Supported by a $16.8 million grant from South Coast AQMD, this initiative aims to enhance sustainability in healthcare logistics.
Owens & Minor published its first Environmental, Social, and Governance (ESG) Report, highlighting its commitment to ESG principles. The report outlines the company's focus areas: Empowering teammates, Caring for customers and communities, Operating responsibly, and Ensuring environmental stewardship. CEO Edward A. Pesicka emphasized that ESG initiatives aim to drive long-term value across operations. Recognized for its achievements, Owens & Minor received multiple awards, including the Level 5 Green Industry Award and the U.S. EPA SmartWay Excellence Award.
Owens & Minor (NYSE: OMI) received two prestigious awards, the 2021 Supplier Legacy Award and the COVID-19 Award for Most Supportive Supplier, recognizing its crucial role in maintaining healthcare supplies during the pandemic. Premier Inc. presented these awards, highlighting Owens & Minor's innovation and leadership. The company swiftly implemented safety protocols and increased manufacturing capabilities to ensure supply resilience. President and CEO Edward A. Pesicka expressed gratitude for the recognition and reaffirmed the company's commitment to advancing healthcare.
Owens & Minor, Inc. (NYSE-OMI) has launched the Owens & Minor Foundation, aimed at promoting healthier communities through financial support and engagement with charitable organizations. The Foundation focuses on Healthcare, Environment, and Diversity and Inclusion. It is backed by an initial endowment of $10 million and will support initiatives like healthcare access, environmental sustainability, and supplier diversity. Company officials emphasized the Foundation's role in extending Owens & Minor's legacy of community service.
Owens & Minor (NYSE-OMI) announced a virtual meeting to discuss its future growth strategy and long-term financial targets. CEO Edward A. Pesicka highlighted a robust performance, projecting adjusted earnings per share exceeding $6.00 by 2026, significantly higher than 2019's adjusted earnings. The company plans to leverage its core business improvements, financial strength, and sustainable growth initiatives, focusing on stakeholder value. The press release notes that GAAP financial forecasting remains impractical due to unpredictable elements, emphasizing reliance on adjusted metrics for future projections.
Owens & Minor reported strong first quarter 2021 financial results, with revenue rising to $2.327 billion from $2.123 billion in 2020. Adjusted net income surged to $111.5 million, translating to $1.57 per share, compared to $2.4 million or $0.04 per share last year. The company has raised its full-year adjusted net income guidance to $3.75 - $4.25 per share due to robust operational execution and favorable market conditions, especially in elective procedures. Additionally, Owens & Minor successfully recapitalized its debt, enhancing financial flexibility.
Owens & Minor (NYSE: OMI) will release its Q1 2021 financial results on May 5, 2021, before NYSE trading begins. The company will host a conference call at 8:00 a.m. EDT to discuss these results, accessible at 866-393-1604. An international dial-in number is also available at 1-224-357-2191, with a replay option for one week. Owens & Minor, a healthcare solutions provider founded in 1882, serves over 4,000 customers globally and aims to empower healthcare advancements.
Owens & Minor, Inc. (NYSE: OMI) has priced its private offering of $500 million senior notes at 4.500% interest due 2029. The offering is set to close on March 10, 2021, pending market conditions. Proceeds will be used to repay outstanding debt from its Term B Loan and Existing Revolving Credit Facility, alongside covering related fees and costs. The notes are offered only to qualified institutional buyers and are not registered under the Securities Act.
Owens & Minor, Inc. (NYSE: OMI) announced a private offering of $500 million in senior notes due 2029, pending market conditions. The proceeds will be utilized to repay outstanding debt under its Term B Loan and existing revolving credit facility, as well as for general corporate purposes. The offering is limited to qualified institutional buyers and non-U.S. persons. The Notes are not registered under the Securities Act and will be offered in compliance with applicable regulations. This offering aims to strengthen the Company's financial position.
Owens & Minor, Inc. (NYSE: OMI) has elected Aster Angagaw and Stephen W. Klemash to its Board of Directors as part of a multi-year succession planning initiative. Angagaw, with extensive experience in transformational growth and leadership roles in healthcare, was last the President of ServiceMaster Brands. Klemash brings significant expertise in finance and governance from Ernst & Young LLP. Their election aims to enhance the company's strategic direction amid evolving industry demands, supporting Owens & Minor's mission of empowering customers in healthcare.